"2021 Drug Digital Intelligence Development Conference" was held in Hefei, Anhui

In order to meet the needs of the digital and intelligent development of the pharmaceutical industry in the new era, explore new ideas and methods for big data technology in the pharmaceutical industry, build a sharing smart supervision exchange platform, maintain a safe network and data position, and promote the high-quality development of the pharmaceutical industry, September 27 From January to 28, the "2021 Drug Digital Intelligence Development Conference" hosted by the Information Center of the State Drug Administration (China Food and Drug Administration Data Center) was held in Hefei, Anhui. Zhang Hongwen, deputy governor of the People's Government of Anhui Province, delivered a welcome speech, and Yan Jiangying, member of the Party Leadership Group and Deputy Director of the National Medical Products Administration, attended the opening ceremony and delivered a speech.
　　 Yan Jiangying pointed out that the in-depth integration of the pharmaceutical industry, drug supervision and information technology is an inevitable development, and it is also a breakthrough point for future supervision and reform. In recent years, the Internet has given birth to big data, and big data has promoted continuous breakthroughs in artificial intelligence, helping the world enter a new era of digital, networked, and intelligent integrated development. In the pharmaceutical industry, we can even feel the tremendous changes brought about by new technologies: evidence-based decision-making based on data has become the basic principle of drug research and development, and the transformation of pharmaceutical companies to digital and intelligent has become the direction of development. E-commerce The in-depth development of modern logistics has become an important way to improve product accessibility. In the future, in the entire process of R&D, production, distribution, and use of drugs, medical devices, and cosmetics, a wave of big data will be surging everywhere, and the power of information technology to reshape the industry will be manifested everywhere.
　　 Yan Jiangying emphasized that smart drug supervision has reached a new level, and the next step is to adhere to "one center", that is, people-centered. Consciously practice the concept of "people first, life first", give full play to the unique advantages of big data to "consolidate people's wisdom, divide people's worries, and alleviate people's difficulties", continue to optimize "Internet + government services", accelerate the realization of "one network", and set up convenience for the people Information is "concentric bridge"; it is necessary to adhere to the "two main lines", that is, to ensure safety and keep the bottom line and promote development to chase the high line. Make informatization methods the "clairvoyance and smooth ears" of the regulatory authorities, strengthen data aggregation, governance, analysis, and utilization, and promote digital management of the entire life cycle. At the same time, use the development of the information service industry to better ensure drug safety, maintain market order, and accelerate product research and development; we must adhere to the "three commons", that is, co-construction, co-governance and sharing. Co-construction is for co-governance, and co-governance is inseparable from sharing. Smart supervision is a systematic project that requires the joint efforts of all parties to build a drug safety firewall.
The theme of this conference is "Data Service Development, Innovation and Intelligence Leading the Future", with the goal of promoting high-quality drug development, coordinating development and safety, coordinating industry needs and regulatory requirements, and continuing to consolidate and expand the results of epidemic prevention and control and economic and social development. Better serve the "six stability" and "six guarantees", and better lead the modernization of drug supervision with informatization.
　　 At the meeting, the "China Food and Drug Regulatory Data Center Anhui Collaborative Innovation Platform" was officially launched, the typical cases of smart drug supervision in 2021 were officially released, and the "UDI Service Public Welfare Platform" was officially launched. The whole system and the whole industry have formed a consensus on accelerating the promotion of smart supervision and industry transformation and upgrading.
In the main forum of the conference, the responsible comrades of the relevant departments of the Ministry of Industry and Information Technology, the State Administration of Market Supervision, and the State Food and Drug Administration respectively made "The current situation and development focus of intelligent manufacturing in the pharmaceutical industry", "Practice and thinking on the construction of smart supervision based on credit data", and "Promote drug traceability step by step" System to enhance the level of drug safety protection", "Digital smart review assists cosmetics innovation and development", "Digital technology promotes drug R&D and regulatory modernization", "Medical device review reform digitalization", "Drug off-site remote inspection and digital intelligence development" theme report. Local bureaus such as the Beijing Municipal Drug Administration, Zhejiang Provincial Drug Administration, and Anhui Provincial Drug Administration shared typical cases of smart supervision. Related information technology companies also shared typical cases.
　　 In order to increase diversified, cross-border, and fusion of thought exchanges, during the meeting, responsible comrades of the provincial bureau were organized to conduct in-depth discussions on the work of drug supervision informatization. In addition to the main venue, the conference also added 4 thematic branches: "Building a New Pattern of Social Co-governance with Credit", "UDI Innovative Application", "Enterprise Digital Factory and Digital Transformation", and "Digital Innovation in Cosmetics Industry". Beijing, Tianjin, Inner Mongolia, Liaoning, Jilin, Zhejiang, Anhui, Jiangxi, Hainan, Chongqing, Sichuan, Tibet, Shaanxi, Gansu, Qinghai, Xinjiang and other 26 provinces (autonomous regions, municipalities) drug regulatory bureaus are mainly responsible comrades or responsible comrades in charge Participated in the conference, and exchanged experience and shared gains on smart supervision work.

Tags： 2021 Drug Digital Intelligence Development Conference,

Copyright statement:If not specified, the articles on this site are all PMR Med originals. Please indicate the source and attach the link to the "2021 Drug Digital Intelligence Development Conference" was held in Hefei, Anhui article for reprinting.